Rege Nephro Co., Ltd. (Headquarters: Sakyo-ku, Kyoto, Representative Director: Toshihiro Ishikiriyama, hereinafter “Rege Nephro”) is pleased to announce that Katsuhisa Yamaguchi, CFO and General Manager of Finance & Administration, has been appointed as a member of the board of directors on December 21, 2021.
<Comment by Toshihiro Ishikiriyama, Representative Director>
Since its establishment in September 2019, Katsuhisa Yamaguchi has been promoting the construction of our management system and making a significant contribution to the financing of Seed and Series A as CFO and General Manager of Finance & Administration. As a member of the board, I am confident that he will continue to work hard to further strengthen the governance system and promote business development toward the initial public offering.
<Overview of Rege Nephro>
Rege Nephro Co., Ltd.
Representative Director: Toshihiro Ishikiriyama
Address: 46-29 Yoshidashimoadachi-cho, Sakyo-ku, Kyoto
Kyoto University Med-Pharm Collaboration Building
Business: R & D, production and sales of therapeutic agents for renal diseases
Established: September 2019
<Inquiries regarding this matter>
Masanori Uchida (Director of Finance & Administration Department)